Literature DB >> 3574239

Flavobacterium group IIb bacteremia: report of a case and review of Flavobacterium infections.

Y Siegman-Igra, D Schwartz, G Soferman, N Konforti.   

Abstract

A case of nonfatal Flavobacterium CDC group IIb bacteremia in a hospitalized woman is presented. The portal of entry of the organism was either an intravenous line or an open, eroded wound associated with bilateral breast carcinoma. Flavobacterium infections in the post-neonatal age group are reviewed.

Entities:  

Mesh：

Year:  1987        PMID： 3574239     DOI： 10.1007/bf00200682

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN： 0300-8584            Impact factor:   3.402


  29 in total

1.  FLAVOBACTERIUM MENINGOSEPTICUM IN ISRAEL.

Authors:  R SELIGMANN; M KOMAROV; R REITLER
Journal:  Br Med J       Date:  1963-12-14

2.  Flavobacterium infection as a cause of bacterial endocarditis. Report of a case, bacteriologic studies, and review of the literature.

Authors:  J SCHIFF; L S SUTER; R D GOURLEY; W D SUTLIFF
Journal:  Ann Intern Med       Date:  1961-09       Impact factor: 25.391

3.  Subacute bacterial endocarditis due to Flavobacterium meningosepticum.

Authors:  S Werthamer; M Weiner
Journal:  Am J Clin Pathol       Date:  1972-03       Impact factor: 2.493

4.  ICU-acquired pneumonia due to Flavobacterium meningosepticum.

Authors:  D Teres
Journal:  JAMA       Date:  1974-05-06       Impact factor: 56.272

5.  Flavobacterium multivorum septicemia in a hemodialyzed patient.

Authors:  C Potvliege; C Dejaegher-Bauduin; W Hansen; M Dratwa; F Collart; C Tielemans; E Yourassowsky
Journal:  J Clin Microbiol       Date:  1984-04       Impact factor: 5.948

6.  Flavobacterium meningosepticum ventriculitis: in vivo and in vitro results with the combinations rifampicin-erythromycin and mezlocillin-cefoxitin.

Authors:  M C Kelsey; A M Emmerson; Y Drabu
Journal:  Eur J Clin Microbiol       Date:  1982-06       Impact factor: 3.267

7.  Colonization of an amputation site by Flavobacterium odoratum after gentamicin therapy.

Authors:  J M Davis; M M Peel; J A Gillians
Journal:  Med J Aust       Date:  1979-12-29       Impact factor: 7.738

8.  Flavobacterium odoratum: a species resistant to a wide range of antimicrobial agents.

Authors:  B Holmes; J J Snell; S P Lapage
Journal:  J Clin Pathol       Date:  1979-01       Impact factor: 3.411

9.  Flavobacterium meningosepticum meningitis: report of selected aspects.

Authors:  I Rios; J J Klimek; E Maderazo; R Quintiliani
Journal:  Antimicrob Agents Chemother       Date:  1978-09       Impact factor: 5.191

10.  A comparison of strains of King's group IIb of Flavobacterium with Flavobacterium meningosepticum.

Authors:  R J Owen; S P Lapage
Journal:  Antonie Van Leeuwenhoek       Date:  1974       Impact factor: 2.271
View more
  12 in total

1.  Increasing incidence of nosocomial Chryseobacterium indologenes infections in Taiwan.

Authors:  P R Hsueh; L J Teng; P C Yang; S W Ho; W C Hsieh; K T Luh
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-08       Impact factor: 3.267

2.  Comparison of Etest and agar dilution method for antimicrobial susceptibility testing of Flavobacterium isolates.

Authors:  P R Hsueh; J C Chang; L J Teng; P C Yang; S W Ho; W C Hsieh; K T Luh
Journal:  J Clin Microbiol       Date:  1997-04       Impact factor: 5.948

3.  Antigenic characterization of the fish pathogen Flavobacterium psychrophilum.

Authors:  E M Crump; M B Perry; S C Clouthier; W W Kay
Journal:  Appl Environ Microbiol       Date:  2001-02       Impact factor: 4.792

4.  Molecular and biochemical heterogeneity of class B carbapenem-hydrolyzing beta-lactamases in Chryseobacterium meningosepticum.

Authors:  S Bellais; D Aubert; T Naas; P Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2000-07       Impact factor: 5.191

5.  Antimicrobial susceptibility of flavobacteria as determined by agar dilution and disk diffusion methods.

Authors:  J C Chang; P R Hsueh; J J Wu; S W Ho; W C Hsieh; K T Luh
Journal:  Antimicrob Agents Chemother       Date:  1997-06       Impact factor: 5.191

6.  Genetic-biochemical analysis and distribution of the Ambler class A beta-lactamase CME-2, responsible for extended-spectrum cephalosporin resistance in Chryseobacterium (Flavobacterium) meningosepticum.

Authors:  S Bellais; L Poirel; T Naas; D Girlich; P Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2000-01       Impact factor: 5.191

7.  Clinical and microbiological characteristics of Flavobacterium indologenes infections associated with indwelling devices.

Authors:  P R Hsueh; L J Teng; S W Ho; W C Hsieh; K T Luh
Journal:  J Clin Microbiol       Date:  1996-08       Impact factor: 5.948

Review 8.  Fatal case of community-acquired bacteremia and necrotizing fasciitis caused by Chryseobacterium meningosepticum: case report and review of the literature.

Authors:  Ching-Chi Lee; Po-Lin Chen; Li-Rong Wang; Hsin-Chun Lee; Chia-Ming Chang; Nan-Yao Lee; Chi-Jung Wu; Hsin-I Shih; Wen-Chien Ko
Journal:  J Clin Microbiol       Date:  2006-03       Impact factor: 5.948

9.  Genetic and biochemical characterization of CGB-1, an Ambler class B carbapenem-hydrolyzing beta-lactamase from Chryseobacterium gleum.

Authors:  Samuel Bellais; Thierry Naas; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2002-09       Impact factor: 5.191

Review 10.  Clinical implications of positive blood cultures.

Authors:  C S Bryan
Journal:  Clin Microbiol Rev       Date:  1989-10       Impact factor: 26.132
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.